Barron's Stem Cell Stocks
7563 views
Rate Now: 1 2 3 4

average rating: 3.00 / 4 ratings
Created by Barrons
DESCRIPTION:

Date updated:05-05-2007

From Barron's 5-7-07

"If wall street believes in following the money, much of its own private cash has gone to stem cells lately (see Wealthy Individuals, States Fund What Bush Won't). And private-equity money could well follow as the science gathers momentum. "There's a whole developing field of socially responsible investing, and I think it hasn't yet looked at critically necessary medicine," says Robert Klein, the real-estate developer who was the driving force behind California's decision to fund stem-cell research. Within three years, more money should come from venture-capital investors, pensions with a social mandate, and the growing pool of socially responsible funds, Klein says."

symbol name last price % change open
  • +
  • GENZ
    Genzyme Corporati
  • $66.19
  • -2.23%
  • $68.34

"Genzyme's (GENZ) stance, for one, is fairly typical of big biotech's. The Cambridge, Mass., company is no stranger to cell-based treatment and therapy, having explored the field for more than a decade. "Cell and gene therapy in the last 20 years has tended to over-promise and under-deliver," says John McPherson, head of its biologic research. Still, Genzyme says it continues to study the field, and this includes watching for small promising companies to buy."

People owning GENZ also tend to own: LRCXWRLDAMGNDNAAMZNBLUDHPQ

TheStreet.com Rating: B- What is this?

  • +
  • MRK
    Merck Co Inc
  • $29.97
  • -1.83%
  • $31.08

"Merck (MRK) has provided funding in exchange for shares -- with warrants to buy more -- in Geron (GERN), a Menlo Park, Calif., biotech company that works with embryonic stem cells."

People owning MRK also tend to own: ACASCLPHPQPHISHFLVZBR

TheStreet.com Rating: C+ What is this?

  • +
  • BSX
    Boston Scientific
  • $7.99
  • +5.69%
  • $7.59

"Boston Scientific (BSX), which makes the nation's top-selling drug-coated heart stent, has a joint venture with Osiris to develop its stem-cell treatment for heart disease."

People owning BSX also tend to own: OSIPOSTKAOGHALSTYCCTB

TheStreet.com Rating: D What is this?

  • +
  • GE
    Gen Electric Co
  • $16.86
  • +1.38%
  • $16.86

"General Electric's (GE) health-care unit has acquired exclusive global rights to distribute a device from ThermoGenesis (KOOL) that extracts and stores stem cells"

People owning GE also tend to own: AIGBACCCOPCVXFNMJNJ

TheStreet.com Rating: C What is this?

  • +
  • OSIR
    Osiris Therapeuti
  • $20.24
  • +1.20%
  • $20.11

"Provacel stem-cell treatment for heart disease."

People owning OSIR also tend to own: AGNCAMSFCWTFXYHSTRXMRHORH

TheStreet.com Rating: D What is this?

  • +
  • VIAC
    Viac
  • $0.00
  • N/A
  • $N/A

"Cord-blood stem-cell treatment for cardiac disease."

People owning VIAC also tend to own: ACTC.OBALXNARIAASTMCELGCRISDNDN

TheStreet.com Rating: D What is this?

  • +
  • KOOL
    Thermogenesis Cor
  • $0.55
  • +10.00%
  • $0.507

"Distribution of device for extracting/storing stem cells."

People owning KOOL also tend to own: NWSSUNHACTC.OBALXNARIAASTM

TheStreet.com Rating: D What is this?

  • +
  • CYTX
    Cytori Therapeuti
  • $3.88
  • +5.72%
  • $3.77

"Make device for extracting stem cells from cord blood."

People owning CYTX also tend to own: ABPATICMGICVAFRPTKYPHMER

TheStreet.com Rating: D- What is this?

  • Page 1 of 2
  • 1
  • 2
previous next

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

latest articles | popular forums
Cramer's Take on Top-Searched St...

Investors were spooked on Wednesday as bleak broad-based corporate outlooks and dismal employment data dominated headlines. Stocks experienced their largest drop in more t...

01.07.09 | 21:39 PM
Top Stocks With Insider Buying, ...

At Stockpickr.com, we strive to keep track of insider purchasing and buybacks each week. Here's the perfect setup in my mind: insiders buying the stock, the company buying ...

01.07.09 | 18:35 PM
'Fast Money' Portfolios of the Week

The traders of CNBC’s "Fast Money" think the current stock market is a traders' market. In order to play a traders' market, you have to nimble. You also have to know whic...

01.07.09 | 17:33 PM
What Should Pfizer Buy?

Pfizer (PFE) CEO Jeff Kindler has hinted that the world’s biggest drugmaker is open to a large-scale acquisition. “The real goal is to grow revenues," he told the Fina...

01.07.09 | 17:12 PM
more articles
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZackAttack
Cartoon Thread
11.15.07 | 20:31 PM From author Gov. Peter Blagojevich
Full Disclosure
11.09.08 | 12:30 PM From author alchemist
more forums
recent answers | popular answers
bubble(1)
Q. I am looking to invest monthly a...
01.07.09 | 23:17 PM Asked by richardjans

A. for index, SPY gets you SandP 500
exposure. IWM gets you small cap US
stocks. EFA is a fund for Europe, Far
East Asia, EEM is for Emerging Markets.

if you go to ishares.com they have a lot
of different products. as a side note,
id say dont touch treasuries here, go
for corporates. especially if youve got
a lot of time head of you.

show all recent stockpickr answers
today 's lists
Biggest % Gainers

Here are some of the largest % gainers from Jan. 7, 2009. more

Stocks Most Likely to Disappoint

This list consists of stocks that have had very nice up move over the last year and may be poised to disappoint going forward. The basis for the list is as follows: 52 w... more

52-Week Highs

Here are some of the biggest stocks that made the 52-week high list on Jan. 7, 2009. more

show all today's lists